{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:54:15Z","timestamp":1755222855867,"version":"3.43.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1023\/a:1019559328424","type":"journal-article","created":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T18:25:54Z","timestamp":1047579954000},"page":"559-562","source":"Crossref","is-referenced-by-count":9,"title":["The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Stavroula","family":"Ziakka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Rammos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanos","family":"Kountouris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Doulgerakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipos","family":"Karakasis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Kourvelou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolas","family":"Papagalanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5087759_CR1","first-page":"236","volume":"40","author":"M Arnadottir","year":"1993","unstructured":"Arnadottir M, Brattstrom L, Simonsen O et al. The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 1993; 40: 236\u2013240","journal-title":"Clin Nephrol"},{"key":"5087759_CR2","first-page":"21","volume":"11","author":"GL Booth","year":"2000","unstructured":"Booth GL, Wang EE. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventic Health Care. CMAJ 2000; 11: 21\u201329","journal-title":"CMAJ"},{"key":"5087759_CR3","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1161\/01.ATV.17.11.2554","volume":"17","author":"AG Boston","year":"1997","unstructured":"Boston AG, Shemin D, Verhofen P et al. Elevated fasting total plasma homocystein levels and cardiovascular disease outcomes in maintenance dialysis patients: a prospective study. Arteriolscler Thromb Vasc Biol 1997; 17: 2554","journal-title":"Arteriolscler Thromb Vasc Biol"},{"key":"5087759_CR4","first-page":"72","volume":"43","author":"P Chauveau","year":"1993","unstructured":"Chauveau P, Chadefaux B.Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993; 43: 72\u201377","journal-title":"Kidney Int"},{"issue":"1\u20132","key":"5087759_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1017286006708","volume":"207","author":"PC Choy","year":"2000","unstructured":"Choy PC, Mymin D, Zhu Q, Dakshinamurti K, O K. Athero-sclerosis risk factors: the possible role of homocysteine. Mol Cell Biochem 2000Apr;207(1\u20132): 143\u2013148","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"5087759_CR6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0024-3205(95)02009-8","volume":"57","author":"G Frauscher","year":"1995","unstructured":"Frauscher G, Karnaukhova E, Muehl A et al. Oral administra-tion of homocysteine leads to increased plasma triglycerides and homocysteic acid-additional mechanisms in homocysteine induced endothelial damage? Life Sci 1995; 57(8): 813-817","journal-title":"Life Sci"},{"key":"5087759_CR7","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI11596","volume":"10","author":"GH Werstuck","year":"2001","unstructured":"Werstuck GH, Lentz SR, Dayal S et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001; 10: 1263\u20131273","journal-title":"J Clin Invest"},{"key":"5087759_CR8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0300-2977(94)00100-6","volume":"46","author":"MJ Janssen","year":"1995","unstructured":"Janssen MJ, van den Berg M, Stehouwer CD, Boers GH. Hyperhomocysteinaemia: a role in the accelerated athero-genesis of chronic renal failure? Neth J Med 1995; 46: 244\u2013251","journal-title":"Neth J Med"},{"key":"5087759_CR9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0272-6386(99)70392-6","volume":"34","author":"BJ Manns","year":"1999","unstructured":"Manns BJ, Burgess ED, Hyndman ME et al. Hyperhomo-cysteiemia and the prevalence of atherosclerotic vascular disease in patients with end stage renal disease. Am J Kidney Dis 1999; 34: 669\u2013677","journal-title":"Am J Kidney Dis"},{"key":"5087759_CR10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0021-9150(90)90165-F","volume":"83","author":"KS McCully","year":"1990","unstructured":"McCully KS, Olszewski AJ, Vezeridis MP. Homocysteine and lipid metabolism in atherogenesis: effect of the homo-cysteine thiolactonyl derivatives, thioretinaco and thioreti-namide. Atheroscerosis 1990; 83: 197\u2013206","journal-title":"Atheroscerosis"},{"key":"5087759_CR11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000045664","volume":"85","author":"D McGregor","year":"2000","unstructured":"McGregor D, Shand B, Lynn K. A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease. Nephron 2000; 85: 215\u2013220","journal-title":"Nephron"},{"key":"5087759_CR12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ajcn\/73.4.759","volume":"73","author":"CM McKinley","year":"2001","unstructured":"McKinley CM, McNulty H, McParthin J et al. Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J of Clin Nutr 2001; 73: 759\u2013764","journal-title":"Am J of Clin Nutr"},{"key":"5087759_CR13","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(96)12049-3","volume":"349","author":"AM Molloy","year":"1997","unstructured":"Molloy AM, Daly S, Mills JL et al. Thermolabile variant of 5, 10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommenda-tions. Lancet 1997; 349: 1591\u20131593","journal-title":"Lancet"},{"key":"5087759_CR14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.CIR.97.2.138","volume":"97","author":"A Moustapha","year":"1998","unstructured":"Moustapha A, Nalso A, Nahlawi M et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end stage renal failure. Circulation 1998; 97: 138\u2013141","journal-title":"Circulation"},{"issue":"2\u20133","key":"5087759_CR15","first-page":"317","volume":"1393","author":"EG Lynn>","year":"1998","unstructured":"O K, Lynn EG, Chung YH et al. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim Biophys Acta 1998 Aug 28; 1393(2\u20133): 317\u2013324","journal-title":"Biochim Biophys Acta"},{"key":"5087759_CR16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0021-9150(91)90262-2","volume":"88","author":"AJ Olszewski","year":"1988","unstructured":"Olszewski AJ, Szostak WB. Homocysteine content of plasma proteins in ischemic heart disease. Atherosclerosis 1988; 88: 97\u201398","journal-title":"Atherosclerosis"},{"key":"5087759_CR17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0021-9150(91)90257-4","volume":"88","author":"AJ Olszewski","year":"1991","unstructured":"Olszewski AJ, McCully KS. Homocysteine content of lipo-proteins in hypercholesterolemia. Atherosclerosis 1991; 88: 61\u201368","journal-title":"Atherosclerosis"},{"issue":"1","key":"5087759_CR18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0021-9150(91)90257-4","volume":"88","author":"AJ Olszewski","year":"1991","unstructured":"Olszewski AJ, McCully KS. Homocysteine content of lipo-proteins in hypercholesterolemia. Atherosclerosis 1991 May; 88(1): 61\u201368","journal-title":"Atherosclerosis"},{"issue":"1","key":"5087759_CR19","first-page":"978","volume":"88","author":"AJ Olszewski","year":"1991","unstructured":"Olszewski AJ, Szostak WB, Bialkowska M et al. Reduc-tion of plasma lipid and homocysteine levels by pyridoxine, folate, covalamin, riboflavin, and troxerutin in atherosclerosis. Atherosclerosis 1991; 88(1): 978","journal-title":"Atherosclerosis"},{"key":"5087759_CR20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0891-5849(93)90151-J","volume":"14","author":"AJ Olszewski","year":"1993","unstructured":"Olszewski AJ, McCully KS. Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radic Biol Med 1993; 14: 683","journal-title":"Free Radic Biol Med"},{"key":"5087759_CR21","doi-asserted-by":"crossref","unstructured":"Qujeq D, Omran TS, Hosini L. Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction. Clin Biochem 2001Mar; 34(2): 97\u2013101","DOI":"10.1016\/S0009-9120(01)00187-4"},{"key":"5087759_CR22","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","volume":"270","author":"J Selhub","year":"1993","unstructured":"Selhub J, Jacques PF, Wilson PWF et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. Jama 1993; 270: 2693\u20132698","journal-title":"Jama"},{"key":"5087759_CR23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000013486","volume":"19","author":"JD Spence","year":"1999","unstructured":"Spence JD, Cordy P, Kortas C, Freeman D. Effect of usual doses of folate supplementation on elevated plasma homo-cysteine in hemodialysis patients: no difference between 1 and 5 mg daily. Am J Nephrol 1999; 19: 405\u2013410","journal-title":"Am J Nephrol"},{"issue":"7","key":"5087759_CR24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0967-2109(00)00062-4","volume":"8","author":"JL Stanford","year":"2000","unstructured":"Stanford JL, Molina H, Phillips J et al. Oral folate reduces plasma homocysteine levels in hemodialysis patients with cardiovascular disease. Cardiovasc Surg 2000; 8(7): 567\u2013571","journal-title":"Cardiovasc Surg"},{"key":"5087759_CR25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1681\/ASN.V1161106","volume":"11","author":"G Sunder-Plassmann","year":"2000","unstructured":"Sunder-Plassmann G, Fodinger M, Buchmayer H et al. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J Am Soc Nephrol 2000; 11: 1106\u20131116","journal-title":"J Am Soc Nephrol"},{"key":"5087759_CR26","first-page":"425","volume":"15","author":"N Weiss","year":"1999","unstructured":"Weiss N, Feussner A, Hailer S et al. Influence of folic acid, pyridoxal phosphate and covalamin on plasma homocysteine levels and the susceptibility of low density lipoprotein to ex-vivo oxidation. Euro J Med Res 1999; 15: 425\u2013432","journal-title":"Euro J Med Res"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1019559328424.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1019559328424\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1019559328424.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T06:06:25Z","timestamp":1754892385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1019559328424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["5087759"],"URL":"https:\/\/doi.org\/10.1023\/a:1019559328424","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"type":"print","value":"0301-1623"},{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}